Mr. Jerry Lai reports

PANGENOMIC HEALTH ANNOUNCES CHANGES TO BOARD OF DIRECTORS

Pangenomic Health Inc. has made changes to its board of directors.

The company announces the resignation of Vincent Lum as a director of the company. Mr. Lum, the previous chief executive officer and a co-founder of Pangenomic Health, will continue to serve as the CEO, president, executive chair and a director of the company's subsidiary, MUJN Diagnostics Inc.

The company is pleased to announce the appointment of Francisco Kent Carasquero as a director of the company. Mr. Carasquero previously served as the vice-president of finance and a director of the company, and has acted as a corporate finance consultant to the company since its listing on the Canadian Securities Exchange.

About Pangenomic Health Inc.

Pangenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. The company's initial focus is to support mental health. Registered as a British Columbia benefit company, Pangenomic Health's mission is to promote and improve the health and wellness of people and society by providing a technology platform that identifies plant-based solutions tailored to the health profile of each individual.

We seek Safe Harbor.